EE9800299A - R-a-propüül-piperonüülamiini ja selle analoogide uudne asümmeetriline sünteesimine - Google Patents

R-a-propüül-piperonüülamiini ja selle analoogide uudne asümmeetriline sünteesimine

Info

Publication number
EE9800299A
EE9800299A EE9800299A EE9800299A EE9800299A EE 9800299 A EE9800299 A EE 9800299A EE 9800299 A EE9800299 A EE 9800299A EE 9800299 A EE9800299 A EE 9800299A EE 9800299 A EE9800299 A EE 9800299A
Authority
EE
Estonia
Prior art keywords
piperonylamine
analogs
propyl
asymmetric synthesis
novel asymmetric
Prior art date
Application number
EE9800299A
Other languages
English (en)
Estonian (et)
Inventor
Eugene Waltermire Robert
Li Hui-Yin
Anzalone Luigi
Original Assignee
The Du Pont Merck Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Du Pont Merck Pharmaceutical Company filed Critical The Du Pont Merck Pharmaceutical Company
Publication of EE9800299A publication Critical patent/EE9800299A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EE9800299A 1996-03-22 1997-03-17 R-a-propüül-piperonüülamiini ja selle analoogide uudne asümmeetriline sünteesimine EE9800299A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1395596P 1996-03-22 1996-03-22
PCT/US1997/003466 WO1997034887A1 (en) 1996-03-22 1997-03-17 NOVEL ASYMMETRIC SYNTHESIS OF R-α-PROPYL-PIPERONYL AMINE AND ITS ANALOGS

Publications (1)

Publication Number Publication Date
EE9800299A true EE9800299A (et) 1999-06-15

Family

ID=21762727

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800299A EE9800299A (et) 1996-03-22 1997-03-17 R-a-propüül-piperonüülamiini ja selle analoogide uudne asümmeetriline sünteesimine

Country Status (23)

Country Link
US (1) US5932749A (cs)
EP (1) EP0888329A1 (cs)
JP (1) JP2000506891A (cs)
KR (1) KR20000064735A (cs)
CN (1) CN1218463A (cs)
AR (1) AR006521A1 (cs)
AU (1) AU719633B2 (cs)
BR (1) BR9708233A (cs)
CA (1) CA2249401A1 (cs)
CZ (1) CZ295098A3 (cs)
EA (1) EA001207B1 (cs)
EE (1) EE9800299A (cs)
HR (1) HRP970165A2 (cs)
IL (1) IL126223A0 (cs)
LT (1) LT4540B (cs)
LV (1) LV12259B (cs)
NO (1) NO984344D0 (cs)
NZ (1) NZ331875A (cs)
PL (1) PL329070A1 (cs)
SI (1) SI9720023A (cs)
SK (1) SK127398A3 (cs)
WO (1) WO1997034887A1 (cs)
ZA (1) ZA972342B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012474A1 (en) 1998-08-31 2000-03-09 Du Pont Pharmaceuticals Company An efficient process for the preparation of a human leukocyte elastase inhibitor
US6825351B2 (en) * 2001-09-12 2004-11-30 Anormed, Inc. Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
NZ592831A (en) * 2008-12-15 2013-06-28 Taigen Biotechnology Co Ltd Stereoselective synthesis of piperidine derivatives
US9126906B2 (en) 2012-02-21 2015-09-08 Celgene Corporation Asymmetric synthetic processes for the preparation of aminosulfone compounds
AR090100A1 (es) 2012-02-21 2014-10-22 Celgene Corp Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
JP6864296B2 (ja) 2015-12-14 2021-04-28 エックス4 ファーマシューティカルズ, インコーポレイテッド がんを処置する方法
WO2017106332A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
EP3393468B1 (en) 2015-12-22 2022-09-14 X4 Pharmaceuticals, Inc. Methods for treating immunodeficiency disease
WO2017177230A1 (en) 2016-04-08 2017-10-12 X4 Pharmaceuticals, Inc. Methods for treating cancer
CN109641838A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
CA3027498A1 (en) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Cxcr4 inhibitors and uses thereof
CA3027495A1 (en) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Cxcr4 inhibitors and uses thereof
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
CN115515585A (zh) 2020-03-10 2022-12-23 X4 制药有限公司 用于治疗中性粒细胞减少症的方法
WO2023034510A1 (en) 2021-09-01 2023-03-09 ATAI Life Sciences AG Synthesis of mdma or its optically active ( r)- or ( s)-mdma isomers
EP4401725A1 (en) * 2021-09-17 2024-07-24 atai Life Sciences AG Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomeric salts
EP4408832A4 (en) 2021-10-01 2025-10-29 Empathbio Inc NEW PRODICTIVES OF MDMA, MDA AND THEIR DERIVATIVES
US11912680B2 (en) 2021-12-28 2024-02-27 Empathbio, Inc. Nitric oxide releasing prodrugs of MDA and MDMA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3819438A1 (de) * 1987-06-30 1989-01-19 Basf Ag Verfahren zur herstellung von optisch aktiven 1-arylethylaminen
IL99658A0 (en) * 1990-10-15 1992-08-18 Merck & Co Inc Substituted azetidinones and pharmaceutical compositions containing them
US5149838A (en) * 1991-09-20 1992-09-22 Merck & Co., Inc. Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents

Also Published As

Publication number Publication date
EA001207B1 (ru) 2000-12-25
AU719633B2 (en) 2000-05-11
CA2249401A1 (en) 1997-09-25
LV12259A (lv) 1999-04-20
HRP970165A2 (en) 1998-04-30
LT4540B (lt) 1999-08-25
JP2000506891A (ja) 2000-06-06
NZ331875A (en) 2000-01-28
WO1997034887A1 (en) 1997-09-25
CZ295098A3 (cs) 1999-03-17
LV12259B (en) 1999-09-20
NO984344L (no) 1998-09-18
AR006521A1 (es) 1999-09-08
BR9708233A (pt) 2000-01-04
LT98132A (en) 1999-03-25
PL329070A1 (en) 1999-03-15
ZA972342B (en) 1998-09-18
KR20000064735A (ko) 2000-11-06
EA199800844A1 (ru) 1999-02-25
SK127398A3 (en) 1999-04-13
NO984344D0 (no) 1998-09-18
EP0888329A1 (en) 1999-01-07
CN1218463A (zh) 1999-06-02
US5932749A (en) 1999-08-03
AU2196897A (en) 1997-10-10
IL126223A0 (en) 1999-05-09
SI9720023A (sl) 1999-04-30

Similar Documents

Publication Publication Date Title
EE9800299A (et) R-a-propüül-piperonüülamiini ja selle analoogide uudne asümmeetriline sünteesimine
NO993068L (no) Ny forbindelsesform
NO990059D0 (no) Analoger av kationiske proteiner
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
BR9509200A (pt) Composição de matéria
LV11983A (lv) Iekskigi lietojams 2-metil-tieno-benzodiazepina zalu preparats
DE69715827D1 (de) Verwendung von aloe extrakt enthaltenden zahnprothesehaftmitteln
ID24458A (id) Modifikasi rheologi in-sito poliolefin
BR9509712A (pt) Composição de redeção de pregas
ID22764A (id) Komposisi pembersih abrasif-semprot
DE69737853D1 (de) Herstellung von L(+)-Lactat
DE69922558D1 (de) Herstellung von Aluminiumoxid
BR9711363A (pt) Sintese de bis-indolilmaleimidas
ID16838A (id) Komposisi dekafluoropentana
DE19781649T1 (de) Herstellung von länglichen Elementen
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen
ID17419A (id) Komposisi dekafluoropentana
ID21769A (id) Komposisi-komposisi cangkokan hasil kopolimerisasi
BR9708718A (pt) Sínteses de aminas substituídas
FI943921L (fi) Vapaan trypsinogeeni-2:n määritys
NO991148D0 (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
NO993069D0 (no) Ny anvendelse av dipeptider
DE69703422D1 (de) Herstellung von Aminophenolen
ID22787A (id) Nitro-benzamida berguna sebagai zat anti - arritimia
DE69704268D1 (de) Herstellung von alpha-fluorketonen